✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Beta Drugs Ltd.

BETA

Market Cap
₹1,807 Cr.
P/E
49.60

Beta Drugs Ltd.

  • Beta Drugs
  • Novartis
  • Syncom Formulations
FAQs on Beta Drugs Ltd. Shareprice

Beta Drugs has given better returns compared to its competitors.
Beta Drugs has grown at ~47.12% over the last 7yrs while peers have grown at a median rate of 14.49%

Beta Drugs is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Beta Drugs is 49.6, while 3 year average PE is 43.21.
Also latest EV/EBITDA of Beta Drugs is 18.2 while 3yr average is 19.79.

View FAQ's On Business
Growth Table
  • Beta Drugs Ltd.
  • Novartis
  • Syncom Formulations
Balance Sheet
  • Beta Drugs Ltd.
  • Novartis
  • Syncom Formulations
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Beta Drugs Ltd.
  • Novartis
  • Syncom Formulations
Cash Flow
  • Beta Drugs Ltd.
  • Novartis
  • Syncom Formulations
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Beta Drugs Ltd.
  • Novartis
  • Syncom Formulations
Quarterly Results
  • Beta Drugs Ltd.
  • Novartis
  • Syncom Formulations
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Beta Drugs Ltd. Financials

Balance sheet of Beta Drugs is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Beta Drugs is increasing.
Latest debt of Beta Drugs is -₹8.83 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹42.15 Crs.

Yes, profit is increasing.
The profit of Beta Drugs is ₹41 Crs for TTM, ₹36.44 Crs for Mar 2024 and ₹30.72 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Beta Drugs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech